In 2012 the American College of Cardiology Foundation and the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies (ASCERT) compared the 5 year effectiveness of CABG versus PCI.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease - PCI
December 28, 2014
This is a retrospective study looking at 2,768,007 Medicare beneficiaries in the US undergoing myocardial revascularization between 2008 and 2012. From a surgical point of view it is interesting to see that the proportion of CABG among all revascularization procedures declined from 24.8% in 2008 to 23.2% in 2012.
Mortality and Treatment Patterns Among Patients Hospitalized With Acute Cardiovascular Conditions During Dates of National Cardiology Meetings
December 23, 2014
This retrospective analysis of patients admitted emergently for acute MI, heart failure, or cardiac arrest examined 30-day mortality for admissions during periods when cardiologists were attending national meetings vs admissions immediately surrounding the meeting dates. Mortality for each condition was lower during meeting dates than during non-mee
November 28, 2014
Shanker Vedantam interviews Jason Hockenberry, an economist at Emory University, regarding recent research into patient behavior following PCI or CABG. CABG patients were more likely to quit smoking after intervention for CAD. This may be a result of the magnitude of the intervention, and has implications for improving smoking cessation programs.
October 19, 2014
In this manuscript, the authors use meta-analysis techniques to evaluate the relationship between measured coronary fractional flow reserve (FFR) and patients’ outcomes.
September 5, 2014
This controlled randomized trial examined the benefits of targeted PCI vs medical therapy alone for patients with stable CAD and stenosis who were found to have zones of fractional flow reserve of less than 0.8 at angiography. Patients without regions of FFR <0.8 were entered into a registry. The composite outcome was death, nonfatal MI, or urg
August 18, 2014
The study aims to compare outcomes between minimally invasive coronary artery bypass (MINI–CAB) and drug–eluting stent (DES) implantation for isolated left anterior descending (LAD) disease. Given the available evidence, MINI–CAB results in lower TVR rates, but otherwise similar clinical outcomes when compared with DES in patients with LAD disease.
Cost-Effectiveness of Percutaneous Coronary Intervention with Drug-Eluting Stents vs. Bypass Surgery for Patients with 3-Vessel or Left Main Coronary Artery Disease: Final Results from the SYNTAX Trial.
August 8, 2014
In this study the cost-effectiveness of CABG vs. DES-PCI was analysed from a U.S. Healthcare perspective. Using 5-year cost and quality-of-life data from the SYNTAX trial and lifetime extrapolations, the authors found that CABG was an economically attractive treatment option for most patients with 3-VD or left main CAD disease.
June 18, 2014
Coronary artery bypass grafting versus drug-eluting stents in patients with severe coronary artery disease and diabetes mellitus: a systematic review and meta-analysis Journal of Diabetes, 06/11/2014 Evidence Based Medicine Review Article
June 4, 2014
Coronary artery bypass grafting (CABG) has been considered the standard of care for patients with three-vessel disease (3VD), but long-term comparative results from randomized trials of CABG vs. percutaneous coronary intervention (PCI) using drug-eluting stents (DES) remain limited.